All News #Library
Others
Curevo Vaccine Announces $26 Million Series A1 Financing
16 Nov 2022 //
BUSINESSWIRE
Curevo concludes subject enrolment in Phase IIb shingles vaccine trial
16 Sep 2022 //
CLINICALTRIALSARENA
Curevo Vaccine Announces Enrollment Complete in Phase 2b Trial of CRV-101
15 Sep 2022 //
PRNEWSWIRE
Curevo will go head-to-head against GSK`s Shingrix with $60M
03 Feb 2022 //
FIERCEBIOTECH
Curevo Vaccine Announces the Approval to Conduct a Phase 1b Clinical Trial
30 Mar 2021 //
BUSINESSWIRE

Market Place
Sourcing Support